Alcohol biomarker screening in medical and surgical settings

Alcohol Clin Exp Res. 2006 Feb;30(2):185-93. doi: 10.1111/j.1530-0277.2006.00029.x.

Abstract

This article highlights the proceedings of a symposium presented at the 28th Annual Meeting of the Research Society on Alcoholism in Santa Barbara, CA, on June 28, 2005, organized and chaired by Peter Miller. The presentations included (1) Screening for Alcohol Use Disorders in Surgical and Trauma Patients, presented by Claudia Spies; (2) Are Serum Levels of %CDT and GGT Related to Severity of Liver Biopsy Inflammation, Fibrosis, and Steatohepatitis in Patients with Hepatitis C? by Martin Javors; (3) Biochemical Alcohol Screening in the Treatment of Hypertension, presented by Peter Miller; and (4) The Cost-Effectiveness of a New Biomarker, CDT, in a Primary Care Sample, by Michael Fleming. Presentations were discussed by Raymond Anton.

Publication types

  • Congress

MeSH terms

  • Alcoholic Intoxication / blood
  • Alcoholic Intoxication / diagnosis*
  • Alcoholism / blood
  • Alcoholism / diagnosis*
  • Biomarkers / blood*
  • Costs and Cost Analysis
  • Humans
  • Liver Diseases, Alcoholic / blood
  • Liver Diseases, Alcoholic / diagnosis
  • Liver Function Tests / economics
  • Mass Screening* / economics
  • Postoperative Complications / blood
  • Postoperative Complications / prevention & control*
  • Predictive Value of Tests
  • Preoperative Care* / economics
  • Primary Health Care / economics
  • Transferrin / analogs & derivatives
  • Transferrin / metabolism
  • Wounds and Injuries / blood
  • Wounds and Injuries / surgery
  • gamma-Glutamyltransferase / blood

Substances

  • Biomarkers
  • Transferrin
  • carbohydrate-deficient transferrin
  • gamma-Glutamyltransferase